New Products

Androgen Receptor (SP107) antibody is intended for qualified laboratories to qualitatively identify by light microscopy the presence of associated antigens in sections of formalin-fixed, paraffin-embedded tissue sections using IHC test methods. This antibody is used as an aid in the identification of Androgen Receptor positivity in human tissues within the context of an antibody panel, the patient's clinical history, and other diagnostic tests evaluated by a qualified pathologist. This antibody is intended for in vitro diagnostic (IVD) use.

Anti-bcl-2 (SP66) Rabbit Monoclonal Primary Antibody is directed against human bcl-2 expressed by B-cells of the mantle zone and interfollicular T cells. This antibody exhibits a cytoplasmic staining pattern and may be used to aid in the identification of follicular lymphomas and diffuse large cell lymphomas. The antibody is intended for qualitative staining in sections of formalin-fixed, paraffin-embedded tissue. This product should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information, and proper controls. This antibody is intended for in vitro diagnostic (IVD) use.

BOB.1 (SP92) used as an aid in the identification of B-cells in germinal centers, mantle cells, and differentiation of lymphomas within the context of an antibody panel, the patient’s clinical history, and other diagnostic tests evaluated by a qualified pathologist.

Anti-c-MYC (Y69) Rabbit Monoclonal Primary Antibody (anti-c-MYC (Y69)) is directed against the transcription factor c-MYC, an important factor in cell cycle regulation. The anti-c-MYC (Y69) antibody exhibits a nuclear staining pattern and may be used to aid in the characterization of lymphoma. This antibody is intended for qualitative staining of sections of formalin-fixed, paraffin-embedded tissue.
This product should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information, and proper controls. This antibody is intended for in vitro diagnostic (IVD) use.

Anti-CD7 (SP94) Rabbit Monoclonal Primary Antibody is directed against the 40kD transmembrane glycoprotein, CD7 which is present in thymocytes and mature T cells. Anti-CD7 (SP94) may be used to aid in the identification of T cell lymphomas.

This antibody is intended for in vitro diagnostic (IVD) use.
Calcitonin (SP17) antibody is intended for qualified laboratories to qualitatively identify by light microscopy the presence of associated antigens in sections of formalin-fixed, paraffin-embedded tissue sections using IHC test methods. This antibody is used as an aid in the identification of thyroid C-cells and diagnosis of thyroid medullary carcinoma within the context of an antibody panel, patient's clinical history, and other diagnostic tests determined by a qualified pathologist.

Anti-CD19 is directed against the CD19 protein. This antibody may be used to detect the CD19 standard and variant proteins in the vast majority of B cell lymphomas including follicular lymphoma, diffuse large B-cell lymphoma and Burkitt lymphoma.

Anti-CD22 is directed against the type 1 integral membrane glycoprotein, CD22. Anti-CD22 (SP104) exhibits a cell membranous and/ or cytoplasmic staining pattern and may be used to aid in the identification of B-cell lymphomas.

CD56 (MRQ-42) used as an aid in the identification of neural/neurodendocrine tissues, natural killer (NK) cells, NK-like T-cells, and diagnosis of related neoplasms within the context of an antibody panel, the patient’s clinical history, and other diagnostic tests evaluated by a qualified pathologist.

CEA (CEA31) used as an aid in the identification and diagnosis of adenocarcinomas within the context of an antibody panel, the patient’s clinical history, and other diagnostic tests evaluated by a qualified pathologist.

This antibody is intended for in vitro diagnostic (IVD) use.
CMV (8B1.2, 1G5.2 & 2D4.2) antibody is intended for qualified laboratories to qualitatively identify by light microscopy the presence of associated antigens in sections of formalin-fixed, paraffin-embedded tissue sections using IHC test methods. Use of this antibody is indicated, subsequent to clinical differential diagnosis, as an aid in the identification of cytomegalovirus within the context of an antibody panel, the patient's clinical history, and other diagnostic tests evaluated by a qualified pathologist.

This product is intended for research use only. Not for use in diagnostic procedures.
Anti-CMV (8B1.2, 1G5.2 & 2D4.2) may be used as the primary antibody for immunohistochmical staining of formulin-fixed, paraffin-embedded tissue sections.
Human cytomegalovirus (CMV) is a β-herpesvirus (human herpesvirus 5) that causes widespread persistent infection. CMV continues to be an important opportunistic pathogen in immunocompromised patients.

DOG1 is used as an aid in the identification and diagnosis of gastrointestinal stromal tumors (GIST) within the context of an antibody panel, the patient’s clinical history, and other diagnostic tests evaluated by a qualified pathologist.

Anti-ERG (EPR3864) Rabbit Monoclonal Primary Antibody (anti-ERG (EPR3864)) is directed against the C-terminus of the ETS transcription regulator, ERG, and is capable of detecting both wildtype ERG, and truncated ERG resulting from ERG gene rearrangement. This antibody exhibits a nuclear staining pattern and may be used to aid in the identification of prostate adenocarcinomas through the detection of truncated ERG.

Anti-Glypican 3 (GC33) Mouse Monoclonal Primary Antibody is directed against the heparan sulfate proteoglycan, glypican 3. This antibody may be used to aid in the differentiation of hepatocellular carcinoma from normal liver or benign lesions.

VENTANA anti-Helicobacter pylori (SP48) Rabbit Monoclonal Primary Antibody is designed to qualitatively detect the presence of Helicobacter pylori in formalin-fixed, paraffin-embedded gastric biopsy tissue via light microscopy. Immunohistochemical staining with this antibody product may aid in the diagnosis of Helicobacter pylori infection. This product should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information and proper controls. This antibody is intended for in vitro diagnostic (IVD) use.

HGAL used as an aid in the identification of follicular lymphoma within the context of an antibody panel, the patient’s clinical history, and other diagnostic tests evaluated by a qualified pathologist.

IgG4 (MRQ-44) antibody is intended for qualified laboratories to qualitatively identify by light microscopy the presence of associated antigens in sections of formalin-fixed, paraffin-embedded tissue sections using IHC test methods. Use of this antibody is indicated as an aid in the diagnosis of IgG4-related sclerosing diseases within the context of an antibody panel, the patient's clinical history, and other diagnostic tests evaluated by a qualified pathologist. This antibody is intended for in vitro diagnostic (IVD) use.

INI-1 (MRQ-27) antibody is intended for qualified laboratories to qualitatively identify by light microscopy the presence of associated antigens in sections of formalin-fixed, paraffin-embedded tissue sections using IHC test methods. This antibody is used subsequent to the diagnosis of malignancy as an aid to classify the disease as malignant rhabdoid tumors within the context of an antibody panel, the patient's clinical history, and other diagnostic tests evaluated by a qualified pathologist. This antibody is intended for in vitro diagnostic (IVD) use.

This antibody is intended for in vitro diagnostic (IVD) use.
LMO2 (SP51) antibody is intended for qualified laboratories to qualitatively identify by light microscopy the presence of associated antigens in sections of formalin-fixed, paraffin-embedded tissue sections using IHC test methods. LIM-only transcription factor-2 (LMO2) antibody is useful in the diagnosis of follicular lymphoma within the context of an antibody panel, the patient's clinical history, and other diagnostic tests evaluated by a qualified pathologist.

Melanoma Triple Cocktail (HMB45+A103+T311) is an antibody cocktail of anti-Melanosome (HMB45), anti-MART-1/melan A (A103), and anti-Tyrosinase (T311) mouse monoclonal antibodies. This antibody cocktail demonstrates cytoplamic staining and may be used to aid in the identification of melanoma. The antibody is intended for qualitative staining in sections of formalin-fixed, paraffin-embedded tissue. This product should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information and proper controls. This antibody is intended for in vitro diagnostic (IVD) use.

Anti-MLH-1 (M1) Mouse Monoclonal Primary Antibody is used to qualitatively identify human DNA mismatch repair (MMR) protein MLH1, expressed in the nucleus of normal proliferating cells. Deficient or low levels of MLH1 are associated with colorectal and other cancers.

Anti-MUC1 (H23) is directed against the membrane bound, glycosylated phosphoprotein MUC1. This antibody may be used to aid in the identification of normal and neoplastic MUC1 expressing cells.

Anti-p57^kip2 (Kp10) antibody is intended for qualified laboratories to qualitatively identify by light microscopy the presence of associated antigens in sections of formalin-fixed, paraffin-embedded tissue sections using IHC test methods. This antibody is used, subsequent to the clinical differential diagnoses of molar pregnancies, as an aid in the recognition of the diseases partial hydatidiform mole, complete hydatidiform, and hydropic abortuses within the context of an antibody panel, the patient's clinical history, and other diagnostic tests evaluated by a qualified pathologist. This antibody is intended for in vitro diagnostic (IVD) use.

PAX-8 (MRQ-50) antibody is intended for qualified laboratories to qualitatively identify by light microscopy the presence of associated antigens in sections of formalin-fixed, paraffin-embedded tissue sections using IHC test methods. This antibody is used subsequent to a clinical diagnosis of malignancy as an aid to determine if the disease can be classified as renal cell carcinoma, thyroid carcinoma, and ovarian non-mucinous carcinoma within the context of an antibody panel, the patient's clinical history, and other diagnostic tests evaluated by a qualified pathologist. This antibody is intended for in vitro diagnostic (IVD) use.

Phosphohistone-H3 is used as an aid in identification of mitotic activity in tumor cells and diagnosis of tumor grade differentiation within the context of an antibody panel, the patient’s clinical history, and other diagnostic tests evaluated by a qualified pathologist.

S100P (16/f5) antibody is intended for qualified laboratories to qualitatively identify by light microscopy the presence of associated antigens in sections of formalin-fixed, paraffin-embedded tissue sections using IHC test methods. Use of this antibody is indicated as an aid in the identification and diagnosis of pancreatic ductal adenocarcinoma and urinary carcinoma within the context of an antibody panel, the patient's clinical history, and other diagnostic tests evaluated by a qualified pathologist. This antibody is intended for in vitro diagnostic (IVD) use.

Smoothelin (R4A) is used as an aid in the distinction of terminally differentiated smooth muscle cells, smooth muscle neoplasms of the gastrointestinal tract and other organs, and staging of bladder carcinoma within the context of an antibody panel, the patient’s clinical history, and other diagnostic tests evaluated by a qualified pathologist.

Synaptophysin is used as an aid in the identification of neuroendocrine neoplasms within the context of an antibody panel, the patient’s clinical history, and other diagnostic tests evaluated by a qualified pathologist.

T-bet is used as an aid in the differentiation of hairy cell leukemia, Hodgkin disease, and precursor B-cell lymphoblastic leukemia/lymphoblastic lymphoma within the context of an antibody panel, the patient’s clinical history, and other diagnostic tests evaluated by a qualified pathologist.

TFE3 (MRQ-37) antibody is intended for qualified laboratories to qualitatively identify by light microscopy the presence of associated antigens in sections of formalin-fixed, paraffin-embedded tissue sections using IHC test methods. Use of this antibody is indicated subsequent to the clinical diagnosis of malignancy as an aid in the recognition of Xp11 translocation renal cell carcinoma and alveolar soft part sarcoma within the context of an antibody panel, the patient's clinical history, and other diagnostic tests evaluated by a qualified pathologist. This antibody is intended for in vitro diagnostic (IVD) use.